蕈样肉芽肿和Sezary综合征分类和分期的修订方案——国际皮肤淋巴瘤学会和欧洲癌症研究治疗特别工作组的建议（待续）  

作　　者：Elise Olsen Eric Vonderheld Nieola Pimpinelli Rein Willemze Youn Kim Robert Knobler Herschel Zackheim Madeleine Duvic Teresa Estraeh Stanford Lamberg Gary Wood Reinhard Dummer Annamari Ranki Gunter Burg Peter Heald Mark Pittelkow Maria-Grazia Bernengo Wolfram Sterry Liliane Laroche Franz Trautinger Sean Whittaker 张培红(译) 陈辉树(审校) 

机构地区：[1]Department of Medicine, Divisions of Dermatology and Oncology, Duke University Medical Center, Durham, NC [2]Department of Dermatology, Johns Hopkins University, Baltimore , MD [3]Department of Dermatological Sciences, University of Florence, Florence, haly [4]Department of Dermatology, Leiden University Medical Center,Leiden, The Netherlands [5]Department of Dermatology, Stanford University Medical Center, Stanford, CA [6]Department of Dermatology, University of Vienna, Vienna, Austria [7]Department of Dermatology, University of Californiaat San Francisco [8]Department of Dermatology, University of Texasat Houston [9]Department of Dermatology, University of Barcelona, Barcelona, Spain [10]Department of Dermatology., University of Wisconsin, Madison [11]Department of Dermatology, University Hospital Zurich, Zurich, Switzerland [12]Department of Dermatology and Venereal Diseases, Helsinki University Hospital, Helsinki, Finland [13]Department of Dermatology, Yale University, New Haven, CT [14]Department of Dermatology, Mayo CLinic, Rochester, MN [15]Department of Dermatology, University of Turin, Turin, Italy [16]Department of Dermatology, Charit e, Humboldt University, Berlin, Germany [17]Department of fmmuno-Dermatology, Hospital Avicenne-University of Paris XIII, Paris, France [18]St John's Institute of Dermatology, Skin Tumour Unit, St Thomas' Hospital, London, United Kingdom [19]不详

出　　处：《白血病．淋巴瘤》2008年第6期466-468,共3页Journal of Leukemia & Lymphoma

摘　　要：ISCL／EORTC推荐蕈样肉芽肿协作组使用皮肤T细胞淋巴瘤（Cutaneous T-cell lymphoma，CTCL）分类及分期修订方案。这个修订方案吸收了自1979年最初的指南发表以来的有关蕈样肉芽肿（Mycosis Fungoides，MF）和Sezary综合征（Sezary syndrome，SS）肿瘤细胞生物学和诊断技术的进展，明确目前影响研究机构和调查者之间有效交流和（或）MF及SS标准化临床实验发展的某些指标，而且为追踪其他有潜在预后意义的指标提供了一个平台。此外，鉴于皮肤淋巴瘤中非MF／非SS亚型预后和临床特点的差异，本方案是特别针对MF和SS的。除了对本修订方案的评估和分期程序做出推荐外，该文还对修订方案的论据做了讨论。

关 键 词：SEZARY综合征 蕈样肉芽肿 修订方案 皮肤淋巴瘤 分类 工作组 皮肤T细胞淋巴瘤 LYMPHOMA 

分 类 号：R739.5[医药卫生—肿瘤]